Back to Blog

Learn More: Pineapple Express Delivery

We introduced Pineapple Express Same/Next-Day Delivery to our patients because we know that fast, reliable, and safe delivery of your medical cannabis is essential. Starting in October 2022, we’re reducing the price for Pineapple Express Delivery to $10.00 and it will be the primary delivery option for qualifying patients. For patients on Direct Billing plans, the $10 shipping fee will be covered by your insurance.

How it Works

Simply choose Pineapple Express as your shipping method and your order will be fast-tracked to same/next day delivery.

Please note, orders that are processed before 12 pm on Monday – Friday qualify for same/next day delivery service. For your convenience, you will receive 2 text messages when packages are 1 hour away and 5 minutes away from being delivered to your address.

Tracking Your Order

To check the status of your order, enter your tracking number into the Pineapple Express website here.

List of Delivery zones

Pineapple Express is available to postal codes in the following areas:

1. Greater Toronto Area (same day)
2. London (same day)
3. Ottawa (next day)
4. Kingston (next day)
5. Windsor (next day)
6. Barrie (next day)
7. Durham (next day)
8. Niagara (next day)

If you are not available at the time of delivery, please contact the delivery driver to provide them with instructions to leave the package in an area that meets the following criteria (within reason):

• The package is sheltered from the weather
• The package cannot be seen from the street or by passers-by
• The entrance is not shared

Direct Billing

If your medical cannabis plan allows for direct billing, your order will be shipped once approved by your provider. The $10 shipping fee is now covered by your insurance.

Feel free to connect with our Client Care Team at 1-844-756-7333 or if you have any questions about Pineapple Express. We’re here to help!

Previous Article
Medical Cannabis – cannabinoids for symptom management in seniors
Chronic pain affects 1 in every 5 Canadians, but it is more common in older persons, with ¼ to ¾ of older adults suffering from chronic pain, which limits their movement and dexterity. Chronic pain is significantly more common among elderly people who live in long-term care settings. The Invisible Epidemic: Senior’s over-index for chronic pain The most used medications to treat chronic pain are opioids. However, there is no evidence of the benefit of opioids in long-term chronic pain management. In fact, observational studies show how prescribed long-term opioids for chronic pain is associated with increased risk of abuse, overdose, fractures, and heart attacks. Considering 66% of seniors take at least five medications, there is rising concern about the risks associated with polypharmacy. Polypharmacy increases the risk of adverse events such as falls, fractures, and hospitalizations. And among seniors in long-term care, >60% take ten or more medications, some of which may be used to manage symptoms associated with the 'Pain Triad,' such as opioids, benzodiazepines, anti-depressants, and anti-psychotics. Most of these medicines are sedating, increasing the risk of delirium, falls, fractures, pulmonary embolisms, and cerebrovascular accidents (CVA). The Potential for Cannabis-based Medicines Medical cannabis is a promising alternative to opioids for the treatment of chronic pain, which is the most common reason for its use. Areas where cannabis has shown promise to date, are in fact covered by drug classes corresponding to the three pillars of the pain triad. More importantly, cannabis is likely to spare patients the side effects associated with opioid use. In addition to chronic pain, many seniors suffer from poor appetite and cachexia. Cannabis has the ability to be a potent anti-nauseant and appetite stimulant. The fastest-growing demographic is those aged 65 and up, which will account for 23% of the population by 2031. They are also the fastest-growing demographic of cannabis users, with a strong desire to learn more about the medication's use. Know someone who might need the access to medical cannabis? Contact our Client Care Team for more information at 1-844-756-7333 or References: 1. Schopflocher, D., Taenzer, P. & Jovey, R. The prevalence of chronic pain in Canada. Pain Res Manag 16, 445–450 (2011). 2. Matsuno, R., Wallace, L., Glanzman, R., Martell, B. & Coplan, P. Long-term efficacy and safety of opioid therapy for chronic non-cancer pain: evidence from randomized and open-label studies. The Journal of Pain 14, S77 (2013). Due to FDA regulatory guidelines, most contemporary phase III RCTs of opioid analgesics for chronic non-cancer pain (CNCP) are 3 months long. Furthermore, conducting placebo-controlled, double-blind RCTs ≥3 months presents ethical and operational challenges. (Purdue Pharma) 3. Chou, R. et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann. Intern. Med. 162, 276–286 (2015) 4. Vogel, L. Two-Thirds of Seniors in Long-term Care Take 10 or More Drugs: CIHI. CMAJ June 10, 2014 186 (9) E309. 5. Abrams, DI. Integrating Cannabis into Clinic Cancer Care. Curr Oncol. 23 (2): S8-S14, 2016
Next Article
Nutritional Considerations in Medical Cannabis
Good nutrition is essential to maintain your health throughout your life. A healthy diet lowers the likelihood of developing chronic disease. People with chronic diseases can manage their symptoms and prevent complications by eating healthy. Furthermore, by knowing what types of meals to consume, or avoid, prior to administering cannabis dosages, patients can develop better wellness regimens for their situation. Let's look at some important nutritional factors to take into account when discussing medical cannabis! What are Omega-3 fats? Omega-3 fatty acids are essential for overall health in people of all ages. They are well-known for their benefits in preventing heart disease in older adults and their involvement in brain and eye development in babies. Omega-3 and omega-6 fatty acids can be found in foods such as meat, eggs, fish, and nuts. Omega-3 fatty acids act as an anti-inflammatory and support optimal health when consumed in sufficient amounts. Omega-3s And Your Endocannabinoid System Most people are unaware of the relationship between omega-3 fatty acids and the endocannabinoid system (ECS), which is thought to be maintained in balance by omega-3 fatty acids. The ECS is a crucial system of neurotransmitters throughout the entire body that plays an important role in: -        Pain -        Hunger -        Stress response -        Inflammation -        Sleep -        Muscle movement -        Energy -        Mood Patients may respond more favourably to their cannabis therapy if their diet contains enough omega-3. According to preclinical mice studies, eating enough omega-3 fats results in increased endocannabinoid signalling and stronger sensitivity to the cannabinoids THC and CBD.[1] Can you combine caffeine with cannabis? Each day, billions of people rely on caffeine to wake up, or to get through that night shift or an afternoon slump. Chemically speaking, caffeine has been found to increase the secretion of adrenaline and cortisol, which increase wakefulness, increase blood pressure and energy levels. They are the cause of caffeine-induced body stimulation. It turns out that cannabis functions similarly. Different cultivars interact with the ECS differently due to their distinct genetic make-up (i.e., cannabinoids, flavonoids, and terpenoids). Some cultivars have a stimulating effect similar to that of caffeine. However, other patients with a history of anxiety or cardiac issues may react negatively to this combination. On the other hand, some patients who battle with low energy and low mood may find this beneficial. Medical Cannabis and Gastrointestinal Health The gastrointestinal (GI) system has cannabinoid receptors, which is why some illnesses, such as irritable bowel syndrome (IBS), often respond effectively to medical cannabis. The GI tract's cannabinoid receptors seem to control symptoms including pain, inflammation, and nausea, which are all frequent IBS symptoms. Bacteria in the GI tract (microbiome) may influence endocannabinoid tone. Bacteria quality can influence mood, gut motility, and brain health. It's interesting to note that some researchers are looking into the relationship between chronic diseases like Parkinson's disease and the gut-brain axis. There have been some theories and proposed mechanisms for how cannabinoids, and CBD in particular, may benefit the microbiota. In one study, cannabinoids were used to improve the health of people with alcohol use disorder (AUD)[2]. AUD frequently results in inadequate nutrition as well as liver, intestinal, and brain injury from alcohol. The study discovered that cannabinoids decreased inflammation, regulated gut bacteria, and decreased intestinal permeability in AUD, all of which were beneficial for the microbiome's general health. If you have questions about your dietary with medical cannabis regimen, please speak to your healthcare practitioner for a tailored medical cannabis treatment plan to your needs! Don’t have a medical cannabis document yet? Book an appointment with a healthcare practitioner today!